Table 1 Clinical and pathological characteristics of included patient samples

From: MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail

Variable

Gastric cancer, N =61

Gender

 Male

39 (64)

 Female

22 (36)

Age

 Median (range)

57 (32–76)

 ⩾55

32 (53)

 <55

29 (47)

Tumor location

 Body

30 (49)

 Antrum

21 (35)

 Cardia

8 (13)

 Other

2 (3)

Histology

 Adenocarcinoma

48 (79)

 Mucinous adenocarcinoma

12 (20)

 Signet ring cell cancer

1 (1)

TNM stage

 I

10 (17)

 II

13 (21)

 III

27 (44)

 IV

11 (18)

Lymph node status

 Metastasis

46 (75)

 No metastasis

15 (25)

Back to article page